These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20159524)

  • 1. New frontiers in pancreatic cancer research.
    Khan GN; di Magliano MP; Simeone DM
    Surg Oncol Clin N Am; 2010 Apr; 19(2):431-51. PubMed ID: 20159524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel targets for pancreatic cancer therapy.
    Philip PA
    Surg Oncol Clin N Am; 2010 Apr; 19(2):419-29. PubMed ID: 20159523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell markers in common cancers - therapeutic implications.
    Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
    Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
    Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic activity and chemotherapy resistance in human pancreatic cancer--influence of cancer stem cells.
    Ischenko I; Seeliger H; Jauch KW; Bruns CJ
    Surgery; 2009 Sep; 146(3):430-4. PubMed ID: 19715799
    [No Abstract]   [Full Text] [Related]  

  • 6. Early detection of pancreatic cancer.
    Eguia V; Gonda TA; Saif MW
    JOP; 2012 Mar; 13(2):131-4. PubMed ID: 22406583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational research. New findings and potential future applications in pancreatic adenocarcinoma.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2012 Mar; 13(2):177-9. PubMed ID: 22406595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental pancreatic cancer.
    Pour PM
    Am J Surg Pathol; 1989; 13 Suppl 1():96-103. PubMed ID: 2633635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic methodologies and their application in colorectal cancer research.
    Ikonomou G; Samiotaki M; Panayotou G
    Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal pancreatic cancer in humans and mice.
    Tuveson DA; Hingorani SR
    Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded by the light: molecular imaging in pancreatic adenocarcinoma.
    Collisson E; Tempero M
    Clin Cancer Res; 2011 Jan; 17(2):203-5. PubMed ID: 21106729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for screening for pancreatic adenocarcinoma in high-risk patients.
    Canto MI
    Semin Oncol; 2007 Aug; 34(4):295-302. PubMed ID: 17674957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Xu X; Strimpakos AS; Saif MW
    JOP; 2011 Jul; 12(4):325-9. PubMed ID: 21737888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors.
    Ali S; Cohen C; Little JV; Sequeira JH; Mosunjac MB; Siddiqui MT
    Diagn Cytopathol; 2007 Oct; 35(10):644-8. PubMed ID: 17854080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
    Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
    J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the tumor microenvironment in the progression of pancreatic cancer.
    Farrow B; Albo D; Berger DH
    J Surg Res; 2008 Oct; 149(2):319-28. PubMed ID: 18639248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer: a plea for good and comprehensive morphological studies.
    Algül H; Schmid RM
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):713-5. PubMed ID: 18617774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers of early pancreatic cancer.
    Goggins M
    J Clin Oncol; 2005 Jul; 23(20):4524-31. PubMed ID: 16002843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.